AG
ONC

AIA Group’s BeOne Medicines Ltd ONC Stock Holding History

AIA Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.74M Buy
26,077
+3,430
+15% +$1.11M 0.11% 125
2025
Q4 		$6.88M Sell
22,647
-9,656
-30% -$3.16M 0.1% 132
2025
Q3 		$11M Buy
32,303
+7,716
+31% +$2.34M 0.19% 78
2025
Q2 		$5.95M Hold
24,587
– – 0.13% 91
2025
Q1 		$6.69M Hold
24,587
– – 0.16% 71
2024
Q4 		$4.54M Buy
24,587
+2,922
+13% +$597K 0.11% 88
2024
Q3 		$4.86M Hold
21,665
– – 0.13% 89
2024
Q2 		$3.09M Buy
21,665
+3,168
+17% +$488K 0.09% 116
2024
Q1 		$2.89M Buy
18,497
+5,181
+39% +$834K 0.09% 110
2023
Q4 		$2.4M Buy
13,316
+1,612
+14% +$292K 0.1% 103
2023
Q3 		$2.11M Buy
11,704
+1,349
+13% +$267K 0.1% 102
2023
Q2 		$1.85M Buy
10,355
+5,621
+119% +$1.29M 0.09% 111
2023
Q1 		$1.02M Buy
4,734
+1,088
+30% +$261K 0.06% 152
2022
Q4 		$802K Sell
3,646
-475
-12% -$87.1K 0.05% 161
2022
Q3 		$556K Buy
4,121
+271
+7% +$46.5K 0.04% 181
2022
Q2 		$623K Buy
3,850
+435
+13% +$68K 0.03% 206
2022
Q1 		$644K Buy
3,415
+2,379
+230% +$506K 0.03% 208
2021
Q4 		$281K Buy
+1,036
New +$350K 0.01% 257

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AIA Group's ONC Position: Q1 2026 in Review

AIA Group increased its BeOne Medicines Ltd (ONC) stake by 15% in Q1 2026, buying an estimated $1.11M and bringing the position to 26,077 shares worth $7.74M. The position accounts for 0.11% of the portfolio, ranked #125.

AIA Group first reported a position in ONC in Q4 2021 and has held it in 18 quarters since. The position peaked at $11M in Q3 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • AIA Group held 26,077 shares of BeOne Medicines Ltd worth $7.74M as of Q1 2026.
  • AIA Group bought 3,430 BeOne Medicines Ltd shares in Q1 2026, an estimated $1.11M.
  • BeOne Medicines Ltd made up 0.11% of AIA Group's portfolio in Q1 2026, its #125 holding.
  • AIA Group first reported a position in BeOne Medicines Ltd in Q4 2021 and has held it in 18 quarters since.
  • AIA Group's BeOne Medicines Ltd position peaked at $11M in Q3 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.